Osaka University has agreed to joint research with Anicom General Insurance, Anicom Advanced Medical Research Institute, and Earth Pharmaceutical Co., Ltd. to prevent periodontal disease in pets and improve the intestinal environment.In addition to collecting data on oral bacteria in pets, MA-T™ is used to develop preventive and therapeutic methods for periodontal disease.
According to Anicom General Insurance, MA-T™ is a technology that generates aqueous radicals with bactericidal action from chlorite ions when necessary, enabling virus inactivation and sterilization.In addition to the medical and new drug fields, applications are also expected in the agriculture, forestry and energy industries.
The effect of gel containing MA-T™ has been confirmed in human oral care, but the joint research will apply this technology to pets.In addition to comparing oral bacteria data in pets with periodontal disease and those in normal conditions, the effects of using MA-T™ in pets on the normalization of oral bacteria, prevention and treatment of oral diseases in pets scheduled to be established.
Periodontal disease in pets is said to trigger serious disease later.According to an analysis by Anicom General Insurance from insurance claim data, when dogs develop periodontal disease, the incidence of heart disease increases by 1.7 times in the following year, and kidney disease increases by 3.5 times. 3.8 times more likely to develop heart disease and 2.7 times more likely to develop kidney disease.
